Pre­sent­ing a live End­points News event: Man­ag­ing a biotech in tur­bu­lent times

3 years ago
Bioregnum

Amidst R&D reshuf­fle, Ver­tex ex­pands its pres­ence in Boston, aim­ing to be­come num­ber one

3 years ago
R&D
Manufacturing

As­traZeneca picks up suite of new Covid-19 an­ti­bod­ies, shin­ing spot­light on Ox­ford-tied start­up

3 years ago
Deals
Coronavirus

Bear mar­ket forces Schol­ar Rock, po­ten­tial­ly years away from piv­otal SMA da­ta, to lay off a fourth of its staff

3 years ago
People
R&D

Fol­low­ing po­ten­tial bil­lion-dol­lar J&J deal, RNA pro­cess­ing biotech Remix re­turns with fresh fi­nanc­ing

3 years ago
Financing

A CRL lat­er, Gilead clears clin­i­cal hold on next-gen HIV drug — af­ter find­ing a new glass vial for it

3 years ago
FDA+
Manufacturing

Agios CSO to de­part amid lay­offs as biotech looks for new drugs to li­cense or ac­quire

3 years ago
People
R&D

Cell and gene ther­a­py con­sult­ing firm sub­mits draft AAV pu­ri­ty guid­ance to FDA

3 years ago
Cell/Gene Tx

Mod­er­na blind­sided by in­ves­ti­ga­tion in­to for­mer CFO Jorge Gomez, com­pa­ny says

3 years ago
People
Pharma

Roche lays out ac­cess am­bi­tions in its ESG strate­gies, in­clud­ing in­no­va­tion and val­ue goals

3 years ago
Pharma
Marketing

In­di­an drug­mak­er seeks to toss 'bloat­ed' bil­lion-dol­lar law­suit over Covid vac­cine can­di­date

3 years ago
Pharma
Law

Re­al world ev­i­dence: Lessons learned from an FDA pi­lot show the lim­its of em­u­lat­ing RCTs

3 years ago
FDA+

Alde­vron and In­scrip­ta ink man­u­fac­tur­ing deal for CRISPR Type-V nu­cle­ase

3 years ago
Deals
R&D

Un­per­suad­ed by the da­ta, FDA re­jects cheap, gener­ic SS­RI as a Covid-19 drug

3 years ago
FDA+
Coronavirus

French court rules against Sanofi in land­mark De­pakine case

3 years ago
Pharma
Law

Pfiz­er-part­nered Zen­tal­is woos new CEO, cob­bles to­geth­er $200M

3 years ago
People
Financing

Covid-19 roundup: Synair­gen turns to post-hoc analy­ses af­ter failed drug tri­al; EU ter­mi­nates Val­ne­va vac­cine ...

3 years ago
Coronavirus

Sh­iono­gi backs F2G in de­vel­op­ing rare-dis­ease an­ti­fun­gal in Eu­rope and Asia

3 years ago
Deals

As­traZeneca, Avil­lion de­tail the piv­otal com­bo asth­ma da­ta they're tak­ing to the FDA

3 years ago
R&D
Pharma

Emer­gent inks $225M cash small­pox deal as Chimerix im­plodes on re­org, FDA trou­ble

3 years ago
Pharma
Manufacturing

Ot­su­ka calls off multi­bil­lion-dol­lar, CKD li­cens­ing deal with Ake­bia in af­ter­math of CRL

3 years ago
Deals
FDA+

Treg space con­tin­ues to heat up as Ab­b­Vie puts up al­most $50M up­front to part­ner with lit­tle-known biotech

3 years ago
Deals

An­oth­er pri­vate eq­ui­ty gi­ant makes a big move in­to biotech as Apol­lo ex­e­cutes €1B play — while life sci stocks ...

3 years ago
Financing

Chi­nese Alzheimer's drug­mak­er says lack of fund­ing, Covid out­break forced it to shut­ter in­ter­na­tion­al PhI­II

3 years ago
R&D
China
First page Previous page 519520521522523524525 Next page Last page
A service from the Financial Times